BioNTech - Ein deutscher Biotech-Riese erwacht (Seite 4164)
eröffnet am 10.10.19 21:59:45 von
neuester Beitrag 04.05.24 10:24:29 von
neuester Beitrag 04.05.24 10:24:29 von
Beiträge: 90.297
ID: 1.313.540
ID: 1.313.540
Aufrufe heute: 7
Gesamt: 8.647.803
Gesamt: 8.647.803
Aktive User: 0
ISIN: US09075V1026 · WKN: A2PSR2 · Symbol: BNTX
86,20
EUR
+0,23 %
+0,20 EUR
Letzter Kurs 03.05.24 Tradegate
Neuigkeiten
05.05.24 · HSBC Zertifikate Anzeige |
03.05.24 · BörsenNEWS.de |
03.05.24 · BörsenNEWS.de |
02.05.24 · wallstreetONLINE Redaktion |
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 41,21 | +28,74 | |
| 8,7200 | +28,42 | |
| 10,155 | +21,04 | |
| 8,1400 | +20,41 | |
| 8,0200 | +19,35 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,9999 | -19,36 | |
| 3,5200 | -21,43 | |
| 3,5000 | -26,24 | |
| 1,7000 | -49,40 | |
| 125,00 | -95,83 |
Beitrag zu dieser Diskussion schreiben
Feedback
In einem sind uns die Chinesen ja voraus: Zeit in der sie die Impfstoffe benutzen:
"He noted that getting the third shot after six months is safe and antibodies quickly increased by 15 to 30 times on the 14th day of inoculation. But the anti-bodies will decrease again after another six months."
https://www.globaltimes.cn/page/202108/1232651.shtml
"He noted that getting the third shot after six months is safe and antibodies quickly increased by 15 to 30 times on the 14th day of inoculation. But the anti-bodies will decrease again after another six months."
https://www.globaltimes.cn/page/202108/1232651.shtml
Antwort auf Beitrag Nr.: 69.168.410 von baggo-mh am 27.08.21 14:56:13
Die AMIS kotzen mich nur noch an-Verbrecherpack (HF/LV) nicht alle Amerikaner!
Zitat von baggo-mh: 400K an die Short seller ausgeliehen.
Gruß
baggo-mh
LV haben nachgeladen
400K an die Short seller ausgeliehen.Gruß
baggo-mh
“I recently heard rumors that the Chinese regulator will approve the shot this month, but also I’ve been hearing that every month,” says Council on Foreign Relations’ Huang Yanzhong. While it’s unclear why the decision is still pending, several Chinese public health experts have suggested giving people a third shot to boost their immunity, and that using a vaccine different from their first two shots would have the biggest impact. “To me, that sounds like a signal for accepting an imported, more effective vaccine,” Huang says. “But it’s not going to be easy to convince the government, as well as the public, to approve a shot made with a new technology.”
Some suspect Chinese regulators are moving slowly because they are simply complete strangers to mRNA pharmaceuticals, compared with authorities in the West that have been dealing with experimental products for years. “The Chinese government is very conservative,” says Huang Linfeng, the RNA researcher. He explains that a tiny minority of mRNA vaccine recipients have reported adverse reactions, such as heart inflammation, that scientists don’t yet understand and might give regulators pause. “The technology is just so new,” Huang says.
https://www.sixthtone.com/news/1008308/will-mrna-covid-19-va…
Ist zwar vom 23.August, trotzdem äußerst lesenswert bzgl. China-Deal.
tomcat69
Some suspect Chinese regulators are moving slowly because they are simply complete strangers to mRNA pharmaceuticals, compared with authorities in the West that have been dealing with experimental products for years. “The Chinese government is very conservative,” says Huang Linfeng, the RNA researcher. He explains that a tiny minority of mRNA vaccine recipients have reported adverse reactions, such as heart inflammation, that scientists don’t yet understand and might give regulators pause. “The technology is just so new,” Huang says.
https://www.sixthtone.com/news/1008308/will-mrna-covid-19-va…
Ist zwar vom 23.August, trotzdem äußerst lesenswert bzgl. China-Deal.
tomcat69
Trading Spotlight
Antwort auf Beitrag Nr.: 69.167.144 von 0x545350 am 27.08.21 13:16:16
Biontech - immer ein, zwei Schritte voraus. Patentaufhebungen sind Geschichte.
Zitat von 0x545350: "Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions in Rwanda and Senegal to Improve Long-Term Vaccine Supply"
https://investors.biontech.de/news-releases/news-release-det…
Nach Südafrika nun Ruanda und der Senegal.
Biontech - immer ein, zwei Schritte voraus. Patentaufhebungen sind Geschichte.
Afrika
Ich lese zwischen den Zeilen, W H O und E U werden zumindest die Projekte kofinanzieren. Immerhin ist UvdL bei Bekanntgabe dabei gewesen. Sonst wären das ja falsche Federn, oder?
Antwort auf Beitrag Nr.: 69.167.144 von 0x545350 am 27.08.21 13:16:16Dann war da doch mehr dahinter letzte Woche mit Merkel-Besuch in Marburg und anschließender Mikropanne. Şahin: "Wir machen das schon" 😎
musst Du bei Siemens erarbeiten ;-)
Durchsuchen
03.05.24 · BörsenNEWS.de · American Express |
03.05.24 · BörsenNEWS.de · Allianz |
02.05.24 · wallstreetONLINE Redaktion · Newron Pharmaceuticals |
01.05.24 · dpa-AFX · Pfizer |
24.04.24 · kapitalerhoehungen.de · Formycon |
| Zeit | Titel |
|---|---|
| 21.03.24 | |
| 25.02.24 | |
| 06.11.23 | |
| 29.08.23 |